News Network

Ann Falsey MD, and Edward Walsh MD, discuss the data and implications for the recent approval of the Moderna RSV vaccine, mRNA 1345 (mRESVIA).

Christian Sandrock, MD, MPH, FCCP, highlights key takeaways on approaching treatment of antimicrobial resistant gram-negative infections as presented in updated IDSA guidelines and ID week 2023.

George Sakoulas, MD, provides key insights on the management of soft tissue infections including the role of single-dose agents and treating patients in an outpatient setting.

An expert in infectious diseases shares treatment considerations and clinical strategies for the management of community acquired pneumonia (CAP).

An infectious disease clinical specialist provides insight on approaching treatment of complicated UTIs and shares the impact of the COVID-19 pandemic on treatment approach as well as the importance of antimicrobial stewardship.

A Discussion on Gram-Negative Pathogens and Managing Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Advances in Treating and Managing Skin and Soft Tissue Infections